James Knox is a Research Scientist at Orion Corporation since August 2023, specializing in medicinal chemistry. Previously, James completed a PhD at The Institute of Cancer Research, focusing on lysine-targeting covalent inhibitors to combat resistance mutations in oncology. Prior to the PhD, James earned a Master's degree from the University of Oxford, conducting research on guanidines as catalysts for fluorination. James also gained experience as a Research & Development Intern at GSK and participated in various academic roles at the University of Oxford, including an undergraduate course development volunteer and a summer intern studying photochemical dyes for microscopy. Educational credentials include a Doctor of Philosophy in Chemistry from The Institute of Cancer Research and a Master's degree in Chemistry from the University of Oxford.
This person is not in the org chart
This person is not in any teams
This person is not in any offices